Literature DB >> 14529628

Conversion of wild-type p53 core domain into a conformation that mimics a hot-spot mutant.

Daniella Ishimaru1, Lenize F Maia, Larissa M Maiolino, Pablo A Quesado, Priscila C M Lopez, Fabio C L Almeida, Ana Paula Valente, Jerson L Silva.   

Abstract

The wild-type p53 protein can be driven into a conformation corresponding to that adopted by structural mutant forms by heterodimerization with a mutant subunit. To seek partially folded states of the wild-type p53 core domain (p53C) we used high hydrostatic pressure (HP) and subzero temperatures. Aggregation of the protein was observed in parallel with its pressure denaturation at 25 and 37 degrees C. However, when HP experiments were performed at 4 degrees C, the extent of denaturation and aggregation was significantly less pronounced. On the other hand, subzero temperatures under pressure led to cold denaturation and yielded a non-aggregated, alternative conformation of p53C. Nuclear magnetic resonance (1H15N-NMR) data showed that the alternative p53C conformation resembled that of the hot-spot oncogenic mutant R248Q. This alternative state was as susceptible to denaturation and aggregation as the mutant R248Q when subjected to HP at 25 degrees C. Together these data demonstrate that wild-type p53C adopts an alternative conformation with a mutant-like stability, consistent with the dominant-negative effect caused by many mutants. This alternative conformation is likely related to inactive forms that appear in vivo, usually driven by interaction with mutant proteins. Therefore, it can be a valuable target in the search for ways to interfere with protein misfolding and hence to prevent tumor development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14529628     DOI: 10.1016/j.jmb.2003.08.026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  Reversible aggregation plays a crucial role on the folding landscape of p53 core domain.

Authors:  Daniella Ishimaru; Luis M T R Lima; Lenize F Maia; Priscila M Lopez; Ana P Ano Bom; Ana P Valente; Jerson L Silva
Journal:  Biophys J       Date:  2004-08-06       Impact factor: 4.033

2.  Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.

Authors:  Petar Stefanov Kovachev; Debapriya Banerjee; Luciana Pereira Rangel; Jonny Eriksson; Murilo M Pedrote; Mafalda Maria D C Martins-Dinis; Katarina Edwards; Yraima Cordeiro; Jerson L Silva; Suparna Sanyal
Journal:  J Biol Chem       Date:  2017-04-18       Impact factor: 5.157

3.  p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis.

Authors:  Saikat Ghosh; Shimul Salot; Shinjinee Sengupta; Ambuja Navalkar; Dhiman Ghosh; Reeba Jacob; Subhadeep Das; Rakesh Kumar; Narendra Nath Jha; Shruti Sahay; Surabhi Mehra; Ganesh M Mohite; Santanu K Ghosh; Mamata Kombrabail; Guruswamy Krishnamoorthy; Pradip Chaudhari; Samir K Maji
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

Review 4.  Potential of rescue and reactivation of tumor suppressor p53 for cancer therapy.

Authors:  Emi Hibino; Hidekazu Hiroaki
Journal:  Biophys Rev       Date:  2022-01-11

5.  Preferred drifting along the DNA major groove and cooperative anchoring of the p53 core domain: mechanisms and scenarios.

Authors:  Yongping Pan; Ruth Nussinov
Journal:  J Mol Recognit       Date:  2010 Mar-Apr       Impact factor: 2.137

Review 6.  Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?

Authors:  Danielly C F Costa; Guilherme A P de Oliveira; Elio A Cino; Iaci N Soares; Luciana P Rangel; Jerson L Silva
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

7.  Folding of a cyclin box: linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor AB pocket domain.

Authors:  Lucía B Chemes; María G Noval; Ignacio E Sánchez; Gonzalo de Prat-Gay
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

Review 8.  Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor.

Authors:  Jerson L Silva; Luciana P Rangel; Danielly C F Costa; Yraima Cordeiro; Claudia V De Moura Gallo
Journal:  Biosci Rep       Date:  2013-07-25       Impact factor: 3.840

9.  The p53 core domain is a molten globule at low pH: functional implications of a partially unfolded structure.

Authors:  Ana Paula D Ano Bom; Monica S Freitas; Flavia S Moreira; Danielly Ferraz; Daniel Sanches; Andre M O Gomes; Ana Paula Valente; Yraima Cordeiro; Jerson L Silva
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

Review 10.  Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins.

Authors:  Jerson L Silva; Tuane C R G Vieira; Mariana P B Gomes; Ana Paula Ano Bom; Luis Mauricio T R Lima; Monica S Freitas; Daniella Ishimaru; Yraima Cordeiro; Debora Foguel
Journal:  Acc Chem Res       Date:  2010-02-16       Impact factor: 22.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.